{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:55:31Z","timestamp":1773467731118,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Niemann\u2013Pick disease type C (NPC) is a rare inherited lysosomal storage disease typified by accumulation of cholesterol and other lipids in late endosomes\/lysosomes, thereby resulting in a spectrum of neurological, psychiatric, and systemic symptoms (notably liver disease). Though it is well-known that NPC exacts a physical and emotional toll on both patients and caregivers, the burden of NPC can vary between patients, while the challenges of living with NPC can evolve over time (i.e., from time of diagnosis to the present day). To further grasp patient and caregiver perceptions and experiences with NPC, we carried out focus group discussions with pediatric and adult individuals with NPC (N\u2009=\u200919), with partial or full representation of the patient by their caregiver. Furthermore, we utilized our NPC focus group discussion to provide guidance on study design parameters and feasibility of prospective investigations aiming to characterize the central manifestations of NPC using neuroimaging, specifically, magnetic resonance imaging (MRI) methodology.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Focus group discussions revealed that neurological signs, including declining cognition, memory loss, and psychiatric symptoms, as well as increasingly impaired mobility and motor function, are among the most pressing past and current concerns for patients and caregivers. Moreover, several participants also expressed concern over a loss of independence, social exclusion, and uncertainty for what the future holds. Caregivers described the challenges that participation in research poses, which included logistical difficulties mainly due to traveling with medical equipment and the need for sedation in a minority of patients when undergoing MRI.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings derived from focus group discussions highlight the outstanding challenges that NPC patients and their caregivers face daily, while also providing direction on the potential scope and feasibility of future studies focusing on the central phenotypes of NPC.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02741-2","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:01:49Z","timestamp":1684598509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The experience of living with Niemann\u2013Pick type C: a patient and caregiver perspective"],"prefix":"10.1186","volume":"18","author":[{"given":"Emma","family":"Golden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"van Gool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariesa","family":"Cay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Goodlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walla","family":"Al-Hertani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8682-163X","authenticated-orcid":false,"given":"Jaymin","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"2741_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT. Niemann\u2013Pick disease type C. Orphanet J Rare Dis. 2010;5:16.","journal-title":"Orphanet J Rare Dis"},{"key":"2741_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.12688\/f1000research.12361.1","volume":"7","author":"A Benussi","year":"2018","unstructured":"Benussi A, Cotelli M, Padovani A, Borroni B. Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC [version 1; peer review: 3 approved]. F1000Research. 2018;7:194.","journal-title":"F1000Research"},{"issue":"8","key":"2741_CR3","first-page":"1109","volume":"1864","author":"N Hammond","year":"2019","unstructured":"Hammond N, Munkacsi AB, Sturley SL. The complexity of a monogenic neurodegenerative disease: more than two decades of therapeutic driven research into Niemann-Pick type C disease. Biochim Biophys Acta (BBA) Mol Cell Biol Lipids. 2019;1864(8):1109\u201323.","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Biol Lipids"},{"issue":"3","key":"2741_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.37349\/ent.2021.00012","volume":"1","author":"X Jiang","year":"2021","unstructured":"Jiang X, Ory DS. Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery. Explor Neuroprot Ther. 2021;1(3):146\u201358.","journal-title":"Explor Neuroprot Ther"},{"key":"2741_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-8-35","volume":"8","author":"M Stampfer","year":"2013","unstructured":"Stampfer M, Theiss S, Amraoui Y, et al. Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis. 2013;8:35.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2741_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajmg.a.32642","volume":"149a","author":"R Spiegel","year":"2009","unstructured":"Spiegel R, Raas-Rothschild A, Reish O, et al. The clinical spectrum of fetal Niemann-Pick type C. Am J Med Genet A. 2009;149a(3):446\u201350.","journal-title":"Am J Med Genet A"},{"issue":"Pt 1","key":"2741_CR7","first-page":"120","volume":"130","author":"M S\u00e9vin","year":"2007","unstructured":"S\u00e9vin M, Lesca G, Baumann N, et al. The adult form of Niemann-Pick disease type C. Brain. 2007;130(Pt 1):120\u201333.","journal-title":"Brain"},{"issue":"2","key":"2741_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40263-018-0599-0","volume":"33","author":"T Rego","year":"2019","unstructured":"Rego T, Farrand S, Goh AMY, et al. Psychiatric and cognitive symptoms associated with Niemann-Pick Type C disease: neurobiology and management. CNS Drugs. 2019;33(2):125\u201342.","journal-title":"CNS Drugs"},{"issue":"4","key":"2741_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/15622975.2018.1441548","volume":"20","author":"O Bonnot","year":"2019","unstructured":"Bonnot O, Klunemann HH, Velten C, Torres Martin JV, Walterfang M. Systematic review of psychiatric signs in Niemann-Pick disease type C. World J Biol Psychiatry. 2019;20(4):320\u201332.","journal-title":"World J Biol Psychiatry"},{"issue":"1","key":"2741_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot T, Moro A, Dardis A, et al. Consensus clinical management guidelines for Niemann-Pick disease type C. Orphanet J Rare Dis. 2018;13(1):50.","journal-title":"Orphanet J Rare Dis"},{"key":"2741_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13023-018-0844-0","volume":"13","author":"M Pineda","year":"2018","unstructured":"Pineda M, Walterfang M, Patterson MC. Miglustat in Niemann-Pick disease type C patients: a review. Orphanet J Rare Dis. 2018;13:140.","journal-title":"Orphanet J Rare Dis"},{"key":"2741_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-020-01363-2","volume":"15","author":"MC Patterson","year":"2020","unstructured":"Patterson MC, Mengel E, Vanier MT, et al. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease type C: a final report of the NPC Registry. Orphanet J Rare Dis. 2020;15:104.","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"2741_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s13023-021-02105-8","volume":"16","author":"E Mengel","year":"2021","unstructured":"Mengel E, Patterson MC, Chladek M, et al. Impacts and burden of Niemann pick type-C: a patient and caregiver perspective. Orphanet J Rare Dis. 2021;16(1):493.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2741_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","volume":"7","author":"MC Patterson","year":"2017","unstructured":"Patterson MC, Clayton P, Gissen P, et al. Recommendations for the detection and diagnosis of Niemann-Pick disease type C: an update. Neurol Clin Pract. 2017;7(6):499\u2013511.","journal-title":"Neurol Clin Pract"},{"key":"2741_CR15","doi-asserted-by":"publisher","first-page":"855157","DOI":"10.3389\/fneur.2022.855157","volume":"13","author":"E Golden","year":"2022","unstructured":"Golden E, Zhang F, Selen DJ, et al. Case report: the imperfect association between craniofacial lesion burden and pain in fibrous dysplasia. Front Neurol. 2022;13:855157.","journal-title":"Front Neurol"},{"issue":"20","key":"2741_CR16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1212\/WNL.0b013e3182563b82","volume":"78","author":"FA Wijburg","year":"2012","unstructured":"Wijburg FA, Sedel F, Pineda M, et al. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology. 2012;78(20):1560\u20137.","journal-title":"Neurology"},{"issue":"1","key":"2741_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-021-01719-2","volume":"16","author":"MC Patterson","year":"2021","unstructured":"Patterson MC, Lloyd-Price L, Guldberg C, et al. Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale. Orphanet J Rare Dis. 2021;16(1):79.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2741_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320.","journal-title":"Neurology"},{"issue":"3","key":"2741_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncpneuro0426","volume":"3","author":"SH Subramony","year":"2007","unstructured":"Subramony SH. SARA\u2014a new clinical scale for the assessment and rating of ataxia. Nat Clin Pract Neurol. 2007;3(3):136\u20137.","journal-title":"Nat Clin Pract Neurol"},{"issue":"10","key":"2741_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.steroids.2013.05.017","volume":"78","author":"M Maekawa","year":"2013","unstructured":"Maekawa M, Misawa Y, Sotoura A, et al. LC\/ESI-MS\/MS analysis of urinary 3\u03b2-sulfooxy-7\u03b2-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann-Pick type C disease. Steroids. 2013;78(10):967\u201372.","journal-title":"Steroids"},{"key":"2741_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","volume":"10","author":"AK Giese","year":"2015","unstructured":"Giese AK, Mascher H, Grittner U, et al. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet J Rare Dis. 2015;10:78.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2741_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ymgme.2020.01.007","volume":"129","author":"R Sidhu","year":"2020","unstructured":"Sidhu R, Kell P, Dietzen DJ, et al. Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease. Mol Genet Metab. 2020;129(4):292\u2013302.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2741_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ymgme.2020.11.005","volume":"131","author":"R Sidhu","year":"2020","unstructured":"Sidhu R, Kell P, Dietzen DJ, et al. Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1. Mol Genet Metab. 2020;131(4):405\u201317.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2741_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10545-013-9626-y","volume":"37","author":"JE Wraith","year":"2014","unstructured":"Wraith JE, Sedel F, Pineda M, et al. Niemann-Pick type C Suspicion Index tool: analyses by age and association of manifestations. J Inherit Metab Dis. 2014;37(1):93\u2013101.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2741_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1037\/h0043688","volume":"55","author":"WK Kirchner","year":"1958","unstructured":"Kirchner WK. Age differences in short-term retention of rapidly changing information. J Exp Psychol. 1958;55(4):352\u20138.","journal-title":"J Exp Psychol"},{"key":"2741_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643\u201362.","journal-title":"J Exp Psychol"},{"key":"2741_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1037\/h0021266","volume":"72","author":"JEC Lappin","year":"1966","unstructured":"Lappin JEC. Use of delayed signal to stop a visual reaction-time response. J Exp Psychol. 1966;72:805\u201311.","journal-title":"J Exp Psychol"},{"issue":"1","key":"2741_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/jir.12691","volume":"64","author":"C Farmer","year":"2020","unstructured":"Farmer C, Adedipe D, Bal VH, Chlebowski C, Thurm A. Concordance of the Vineland Adaptive Behavior Scales, second and third editions. J Intellect Disabil Res. 2020;64(1):18\u201326.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"2741_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.tips.2021.11.005","volume":"43","author":"R van Gool","year":"2022","unstructured":"van Gool R, Tucker-Bartley A, Yang E, et al. Targeting neurological abnormalities in lysosomal storage diseases. Trends Pharmacol Sci. 2022;43(6):495\u2013509.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"2741_CR30","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s11011-021-00782-9","volume":"36","author":"P Wibawa","year":"2021","unstructured":"Wibawa P, Kurth F, Luders E, et al. Differential involvement of hippocampal subfields in Niemann-Pick type C disease: a case\u2013control study. Metab Brain Dis. 2021;36(7):2071\u20138.","journal-title":"Metab Brain Dis"},{"issue":"10","key":"2741_CR31","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1007\/s00415-021-10535-4","volume":"268","author":"TY Lau","year":"2021","unstructured":"Lau TY, Kao YH, Toh HB, et al. Brain hypometabolic changes in 14 adolescent-adult patients with Niemann-Pick disease type C assessed by 18F-fluorodeoxyglucose positron emission tomography. J Neurol. 2021;268(10):3878\u201385.","journal-title":"J Neurol"},{"issue":"16","key":"2741_CR32","doi-asserted-by":"publisher","first-page":"e1716","DOI":"10.1212\/WNL.0000000000009287","volume":"94","author":"M Walterfang","year":"2020","unstructured":"Walterfang M, Di Biase MA, Cropley VL, et al. Imaging of neuroinflammation in adult Niemann-Pick type C disease: a cross-sectional study. Neurology. 2020;94(16):e1716\u201325.","journal-title":"Neurology"},{"issue":"5","key":"2741_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s00259-019-4273-7","volume":"46","author":"VL Villemagne","year":"2019","unstructured":"Villemagne VL, Velakoulis D, Dore V, et al. Imaging of tau deposits in adults with Niemann-Pick type C disease: a case\u2013control study. Eur J Nucl Med Mol Imaging. 2019;46(5):1132\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2741_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13023-022-02601-5","volume":"18","author":"S Acaster","year":"2023","unstructured":"Acaster S, Lo SH, Nestler-Parr S. A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosis. Orphanet J Rare Dis. 2023;18(1):17.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2741_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40273-022-01197-9","volume":"41","author":"E Landfeldt","year":"2023","unstructured":"Landfeldt E, Abner S, Pechmann A, et al. Caregiver burden of spinal muscular atrophy: a systematic review. Pharmacoeconomics. 2023;41(3):275\u201393.","journal-title":"Pharmacoeconomics"},{"issue":"13","key":"2741_CR36","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.3390\/ijerph19138208","volume":"19","author":"C Valcarcel-Nazco","year":"2022","unstructured":"Valcarcel-Nazco C, Ramallo-Farina Y, Linertova R, Ramos-Goni JM, Garcia-Perez L, Serrano-Aguilar P. Health-related quality of life and perceived burden of informal caregivers of patients with rare diseases in selected European countries. Int J Environ Res Public Health. 2022;19(13):8208.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"2741_CR37","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/ijerph18073724","volume":"18","author":"B Gomez-Zuniga","year":"2021","unstructured":"Gomez-Zuniga B, Pulido R, Pousada M, Armayones M. The role of parent\/caregiver with children affected by rare diseases: navigating between love and fear. Int J Environ Res Public Health. 2021;18(7):3724.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02741-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02741-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02741-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:04:18Z","timestamp":1684598658000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02741-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2741"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02741-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"18 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Boston Children\u2019s Hospital, Institutional Review Board. All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Al-Hertani is a site Principal Investigator for the Early Access Program with Arimoclomol in US Patients with NPC (NCT04316637), which is sponsored by KemPharm Denmark A\/S. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}